CLGN CollPlant Biotechnologies Ltd

Fundamentals / CIK 0001631487 / USD
Other share classes on CIK 0001631487: OPHI

CollPlant Biotechnologies Ltd reported $2.37M in revenue and a net loss of $11.49M for the fiscal year ended December 31, 2025 (up 360.4% year over year), with a 64.8% gross margin and a -484.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CLGN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$17.20M$8.60M$0-$17.15MFY 2017 Revenue: $463KFY 2017 Net Income: -$6.05M2017FY 2018 Revenue: $5.01MFY 2018 Net Income: -$6.25M2018FY 2019 Revenue: $2.32MFY 2019 Net Income: -$11.16M2019FY 2020 Revenue: $6.14MFY 2020 Net Income: -$5.77M2020FY 2021 Revenue: $15.64MFY 2021 Net Income: $237K2021FY 2022 Revenue: $299KFY 2022 Net Income: -$16.93M2022FY 2023 Revenue: $10.96MFY 2023 Net Income: -$7.02M2023FY 2024 Revenue: $515KFY 2024 Net Income: -$16.61M2024FY 2025 Revenue: $2.37MFY 2025 Net Income: -$11.49M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.37M $515K $10.96M $299K $15.64M $6.14M $2.32M $5.01M $463K
Cost of Revenue $835K $1.62M $1.99M $400K $2.00M $3.00M $1.88M $1.66M $48K
Gross Profit $1.54M -$1.11M $8.97M -$101K $13.64M $3.13M $439K $3.35M $415K
Research & Development $8.19M $10.52M $10.48M $10.26M $7.63M $4.07M $4.41M $3.88M $584K
Selling, General & Admin -- -- -- -- -- -- $3.66M $3.72M $2.47M
Total Operating Expenses -- -- -- -- -- $34K $3.30M $2.18M --
Operating Income -$11.48M -$17.25M -$7.51M -$17.10M $65K -$5.60M -$7.63M -$4.25M -$5.96M
EBITDA -$10.57M -$16.21M -$6.41M -$16.02M $838K -$4.94M -$7.09M -$3.90M -$5.73M
Interest Income $380K $738K $788K $321K $219K -- -- $440K $74K
Interest Expense -- -- -- -- -- -- $3.30M $2.18M $47K
Income Tax Expense -- $45.99M $59.99M -- -- -- -- -- --
Net Income -$11.49M -$16.61M -$7.02M -$16.93M $237K -$5.77M -$11.16M -$6.25M -$6.05M
Basic EPS -$0.94 -$1.45 -$0.62 -$1.53 $0.02 -$0.84 -$2.23 $1.43 --
Diluted EPS -$0.94 -$1.45 -$0.62 -$1.53 $0.02 -$0.84 -$2.23 $1.43 --
Basic Shares Outstanding 12.2M 11.5M 11.4M 11.0M 10.0M 6.9M 5.0M 4.4M 2.7M
Diluted Shares Outstanding 12.2M 11.5M 11.4M 11.0M 12.0M 6.9M 5.0M 4.4M 2.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for CLGN.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.59M $11.91M $26.67M $29.65M $13.15M $3.33M $3.79M $5.35M $4.75M
Cash & Short-Term Investments $5.59M $11.91M $26.67M $29.65M $13.15M $3.33M $3.79M $5.35M $4.75M
Accounts Receivable, Net $1.0K $150K -- $9.0K $270K $830K $79K -- --
Inventory $573K $440K $714K $1.43M $1.08M $1.26M $888K $814K $202K
Total Current Assets $6.75M $13.18M $28.02M $31.66M $45.09M $5.68M $5.04M $7.17M $6.46M
Property, Plant & Equipment, Net $1.46M $2.29M $2.79M $2.97M $2.73M $2.11M $2.33M $1.41M $1.03M
Intangible Assets $73K $131K $188K $245K $243K $82K -- -- --
Total Non-Current Assets $4.04M $5.53M $6.10M $6.11M $6.14M $5.17M $5.71M $1.58M $1.62M
Total Assets $10.79M $18.71M $34.13M $37.77M $51.22M $10.84M $10.75M $8.75M $8.09M
Accounts Payable $610K $870K $980K $1.13M $1.03M $798K $833K $622K $843K
Short-Term Debt -- -- -- $321K $219K -- -- -- --
Deferred Revenue (Current) -- -- -- -- $32K $207K $942K $970K --
Total Current Liabilities $2.67M $2.97M $3.25M $3.10M $3.01M $3.39M $3.46M $2.23M $1.42M
Long-Term Debt -- -- -- -- -- $11K $68K $97K $41K
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $980K --
Total Non-Current Liabilities $2.03M $2.27M $2.54M $2.38M $3.09M $2.98M $3.21M $1.10M $4.05M
Total Liabilities $4.70M $5.25M $5.79M $5.49M $6.10M $6.36M $6.66M $3.33M $5.47M
Total Debt (incl. Leases) $2.85M $3.08M $3.16M $3.23M $3.83M $3.40M $3.66M $97K $41K
Common Stock $5.49M $4.98M $4.98M $4.87M $4.66M $2.93M $2.37M -- --
Retained Earnings -$124.8M -$113.3M -$96.74M -$89.72M -$72.80M -$73.03M -$67.26M -$56.10M -$50.30M
Accumulated Other Comp. Income -$969K -$969K -$969K -$969K -- -- -- -- --
Total Stockholders' Equity $6.08M $13.46M $28.34M $32.28M $45.12M $4.48M $4.09M $5.42M $5.17M
Total Equity $6.08M $13.46M $28.34M $32.28M $45.12M $4.48M $4.09M $5.42M $5.17M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Cash & Cash Equivalents $5.59M $11.91M $26.67M $29.65M $13.15M $3.33M $3.79M $5.35M
Cash & Short-Term Investments $5.59M $11.91M $26.67M $29.65M $13.15M $3.33M $3.79M $5.35M
Accounts Receivable, Net $1.0K $150K -- $9.0K $270K $830K $79K --
Inventory $573K $440K $714K $1.43M $1.08M $1.26M $888K $814K
Total Current Assets $6.75M $13.18M $28.02M $31.66M $45.09M $5.68M $5.04M $7.17M
Property, Plant & Equipment, Net $1.46M $2.29M $2.79M $2.97M $2.73M $2.11M $2.33M $1.41M
Intangible Assets $73K $131K $188K $245K $243K $82K -- --
Total Non-Current Assets $4.04M $5.53M $6.10M $6.11M $6.14M $5.17M $5.71M $1.58M
Total Assets $10.79M $18.71M $34.13M $37.77M $51.22M $10.84M $10.75M $8.75M
Accounts Payable $610K $870K $980K $1.13M $1.03M $798K $833K $622K
Short-Term Debt -- -- -- $321K $219K -- -- --
Deferred Revenue (Current) -- -- -- -- $32K $207K $942K $970K
Total Current Liabilities $2.67M $2.97M $3.25M $3.10M $3.01M $3.39M $3.46M $2.23M
Long-Term Debt -- -- -- -- -- $11K $68K $97K
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $980K
Total Non-Current Liabilities $2.03M $2.27M $2.54M $2.38M $3.09M $2.98M $3.21M $1.10M
Total Liabilities $4.70M $5.25M $5.79M $5.49M $6.10M $6.36M $6.66M $3.33M
Total Debt (incl. Leases) $2.85M $3.08M $3.16M $3.23M $3.83M $3.40M $3.66M $97K
Common Stock $5.49M $4.98M $4.98M $4.87M $4.66M $2.93M $2.37M --
Retained Earnings -$124.8M -$113.3M -$96.74M -$89.72M -$72.80M -$73.03M -$67.26M -$56.10M
Accumulated Other Comp. Income -$969K -$969K -$969K -$969K -- -- -- --
Total Stockholders' Equity $6.08M $13.46M $28.34M $32.28M $45.12M $4.48M $4.09M $5.42M
Total Equity $6.08M $13.46M $28.34M $32.28M $45.12M $4.48M $4.09M $5.42M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.49M -$16.61M -$7.02M -$16.93M $237K -$5.77M $11.16M -$6.25M -$6.05M
Depreciation & Amortization $912K $1.04M $1.10M $1.08M $773K $660K $539K $342K $230K
Stock-Based Compensation $999K $1.72M $1.94M $2.17M $1.60M $1.67M $1.12M $1.43M $956K
Change in Working Capital -- -- -- -- -- -$1.12M $247K -$1.15M --
Change in Receivables $149K -$150K $9.0K $261K $560K -$751K $437K -$439K -$38K
Change in Inventory -$129K $280K $749K -$312K $181K -$374K -$74K -$653K -$59K
Change in Payables -$260K -$110K -$153K $99K $236K -$35K $228K -$112K --
Operating Cash Flow -$9.42M -$14.09M -$2.76M -$13.70M $2.50M -$4.45M -$5.70M -$1.22M -$4.97M
Capital Expenditure -$28K -$483K -$954K -$1.27M -$1.43M -$437K -$1.49M -$832K -$127K
Free Cash Flow -$9.45M -$14.58M -$3.72M -$14.97M $1.07M -$4.89M -$7.19M -$2.05M -$5.09M
Purchases of Investments -- -- -- -$20.00M -$30.00M -- -- -- --
Investing Cash Flow -$27K -$539K -$1.16M $28.92M -$31.56M -$519K -$1.46M -$832K -$127K
Common Stock Issued -- -- -- -- $50K -- $5.44M $2.78M $8.15M
Financing Cash Flow $3.10M $9.0K $1.11M $1.87M $38.76M $4.46M $5.41M $2.75M $9.11M
Net Change in Cash -$6.32M -$14.77M -$3.19M $16.49M $9.85M -$445K -$1.75M $704K $4.01M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for CLGN.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 64.8% -215.5% 81.8% -33.8% 87.2% 51.1% 18.9% 66.9% 89.6%
Operating Margin -484.3% -3349.7% -68.5% -5718.1% 0.4% -91.2% -329.2% -84.7% -1286.6%
Net Profit Margin -484.6% -3225.0% -64.0% -5660.5% 1.5% -94.1% -481.6% -124.6% -1306.9%
Return on Equity (ROE) -188.9% -123.3% -24.8% -52.4% 0.5% -129.0% -273.1% -115.3% -117.0%
Return on Assets (ROA) -106.5% -88.8% -20.6% -44.8% 0.5% -53.3% -103.8% -71.4% -74.8%
Current Ratio 2.53x 4.44x 8.62x 10.20x 14.96x 1.68x 1.46x 3.21x 4.56x
Quick Ratio 2.31x 4.29x 8.40x 9.74x 14.60x 1.30x 1.20x 2.85x 4.41x
Debt to Equity 0.47x 0.23x 0.11x 0.10x 0.08x 0.76x 0.90x 0.02x 0.01x
Revenue Growth (YoY) +360.4% -95.3% +3565.2% -98.1% +154.9% +164.8% -53.8% +982.9% --
Gross Profit Growth (YoY) -- -112.4% -- -100.7% +335.0% +614.1% -86.9% +708.4% --
Operating Income Growth (YoY) -- -- -- -26403.1% -- -- -- -- --
Net Income Growth (YoY) -- -- -- -7241.4% -- -- -- -- --
EPS Growth (YoY) -- -- -- -7750.0% -- -- -255.9% -- --
Operating Cash Flow Growth (YoY) -- -- -- -647.7% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -1495.3% -- -- -- -- --
5Y Revenue / Share Growth -78.2% -90.3% -15.9% -84.4% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for CLGN.
Source: SEC EDGAR CompanyFacts (CIK 0001631487) · from December 31, 2017 Data through December 31, 2025 · synced Nov 21, 2026, 05:08 UTC · Open in terminal